Delivery Order SPE2DB22D1106-SPE2DB25FEYZ8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pregnyl 10,000 Unit Vials with a ceiling value of $3,022.50. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,489.70 firm-fixed-price contract is for the supply of PREGNYL 10,000 UNIT VIALS, a medical product, with a completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
- The Defense Logistics Agency Troop Support Medical awarded a $670.30 firm fixed price delivery order to Amerisourcebergen Drug Corp for 10,000 PREGNYL 10,000 unit vials. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products from its Conshohocken, Pennsylvania facility by July 18, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The delivery order was issued against an...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,388.96 firm fixed-price contract is for the delivery of 4,565,131,503 vials of Pregnyl 10,000 unit medication. The contract has a completion date of July 15, 2024 and was awarded on July 12, 2024. There is no set-aside designation for this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 10,000-unit vials of the medication Pregnyl. The $2,418.00 contract has a performance period through June 23, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for various government...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.00, is for the supply of 10,000 unit vials of the medication Pregnyl. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $4,784.39, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,415,725 units of Pregnyl 10,000 unit vials, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2023 and is a firm fixed-price delivery order. The contract was awarded on October 6, 2023 and does not have a set-aside designation,...
- This federal contract award, valued at $3,240.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 unit vials of the medication Pregnyl, a hormone treatment. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency Troop Support Medical awarded a $268 firm fixed price delivery order to Amerisourcebergen Drug Corp for 10,000 PREGNYL injection vials. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill requirements under the contract. The single day period of performance from September 26 to 27, 2023 indicates this is a one-time delivery order placed against Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.00, is a Delivery Order for the supply of PREGNYL 10,000 UNIT VIALS. The contract has an ultimate completion date of January 27, 2025 and utilizes a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYZ8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,627.00 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with performance completed by July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs globally. The company's federal contracting relationship with DLA demonstrates its established capability to meet federal procurement requirements for pharmaceutical products across multiple therapeutic domains serving Defense Health Agency, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/22/25 |